Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy: Results from a Monocentric Biophysical Risk Evaluation
2024

Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy

Sample size: 25 publication 10 minutes Evidence: moderate

Author Information

Author(s): Baehr Andrea, Schäfer Sebastian, Jäckel Maria, Becker Saskia Alexandra, Ghandili Susanne, Grohmann Maximilian, Eich Hans Theodor, Oertel Michael, Camphausen Kevin

Primary Institution: Department of Radiation Oncology, University Hospital of Hamburg-Eppendorf

Hypothesis

The study aims to compare two different radiation therapy planning variants for patients with primary mediastinal B-cell lymphoma to minimize long-term toxicities.

Conclusion

The study showed that VMAT planning resulted in a decreased risk of different normal tissue complication probabilities for thoracic toxicities compared to APPA planning.

Supporting Evidence

  • VMAT planning showed lower median doses for the heart and lungs compared to APPA planning.
  • Significant differences in mean NTCPs were observed for increased cardiac mortality, pneumonitis, and esophagitis between the two planning methods.
  • PTV size correlated with increased cardiac mortality and esophagitis in both plan variations.

Takeaway

This study looked at how different types of radiation therapy can affect young patients with a rare type of lymphoma, finding that one method is better at reducing harmful side effects.

Methodology

The study involved designing two radiation therapy plans for a cohort of 25 patients and calculating normal tissue complication probabilities for heart, lung, and esophageal toxicity.

Potential Biases

The use of a biophysical model did not account for preexisting conditions that could affect toxicity outcomes.

Limitations

The small cohort size may have led to distortions, and the study did not consider preexisting morbidities or advanced techniques like proton therapy.

Participant Demographics

The cohort included 25 patients, predominantly young, with a median age of 35 years, and included both male and female patients.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244265

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication